• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗东北部医院获得性碳青霉烯类耐药鲍曼不动杆菌、相关因素及临床结局。

Nosocomial carbapenem-drug resistant Acinetobacter baumannii, related factors and clinical outcomes in Northeast Iran.

机构信息

Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran.

Ischemic Disorders Research Center, Department of Biostatistics and Epidemiology, School of Health, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

BMC Infect Dis. 2024 Oct 4;24(1):1103. doi: 10.1186/s12879-024-09972-z.

DOI:10.1186/s12879-024-09972-z
PMID:39367345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11451023/
Abstract

BACKGROUND AND OBJECTIVES

Nosocomial infections, including drug-resistant Acinetobacter baumannii infections, continue to impact the health of hospitalized patients. This study sought to determine the prevalence of these infections and assess the associated risk factors and clinical outcomes in Gorgan, Iran.

METHODS

A retrospective cross-sectional study was conducted on 143 infected patients with Acinetobacter baumannii in two educational hospitals in Gorgan city, Iran between 2016 and 2018. Patient information including age, gender, reason and duration of hospitalization, background of diseases, type of sample culture, symptoms, laboratory findings, prescribed antibiotics, and antibiogram were collected and analyzed. The Logistic regression and survival statistical methods were used by software of SPSS 26.

RESULTS

A total of 37 patients (25.87%) died during hospitalization. The less than one year and 45-65 years age groups demonstrated more deaths (29.7%; p-value < 0.001). Being single (not being married) was found to be a risk factor in increasing the chance of death among patients (OR = 2.154, 95% CI: 1.02-4.53; p = 0.048). Hospitalization in intensive care units (ICUs) was a risk factor for the death of patients (OR = 4.655, 95% CI: 7.6-83.2). The resistance to carbapenems was reported to be an important risk factor for the death of patients.

CONCLUSIONS

Acinetobacter baumannii infections, particularly those resistant to carbapenems, are a significant risk for patients in ICUs and can lead to higher mortality rates.

摘要

背景与目的

医院感染(包括耐碳青霉烯鲍曼不动杆菌感染)持续影响住院患者的健康。本研究旨在确定这些感染在伊朗戈尔甘的流行情况,并评估相关的危险因素和临床结局。

方法

回顾性横断面研究于 2016 年至 2018 年在伊朗戈尔甘市的两所教学医院对 143 例感染鲍曼不动杆菌的患者进行。收集并分析患者的信息,包括年龄、性别、住院原因和时间、疾病背景、样本培养类型、症状、实验室发现、所开抗生素和药敏试验结果。采用 SPSS 26 软件进行 Logistic 回归和生存统计分析。

结果

共有 37 例(25.87%)患者在住院期间死亡。1 年以下和 45-65 岁年龄组的死亡率更高(29.7%;p 值<0.001)。单身(未婚)被发现是增加患者死亡几率的危险因素(OR=2.154,95%CI:1.02-4.53;p=0.048)。入住重症监护病房(ICU)是患者死亡的危险因素(OR=4.655,95%CI:7.6-83.2)。对碳青霉烯类药物的耐药性被报道是患者死亡的重要危险因素。

结论

鲍曼不动杆菌感染,特别是对碳青霉烯类药物耐药的感染,对 ICU 中的患者是一个重大风险,可能导致更高的死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d078/11451023/7480659a0994/12879_2024_9972_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d078/11451023/7480659a0994/12879_2024_9972_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d078/11451023/7480659a0994/12879_2024_9972_Fig1_HTML.jpg

相似文献

1
Nosocomial carbapenem-drug resistant Acinetobacter baumannii, related factors and clinical outcomes in Northeast Iran.伊朗东北部医院获得性碳青霉烯类耐药鲍曼不动杆菌、相关因素及临床结局。
BMC Infect Dis. 2024 Oct 4;24(1):1103. doi: 10.1186/s12879-024-09972-z.
2
Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant infections in critically ill children.重症儿童耐碳青霉烯类感染的流行病学、危险因素和临床结局的研究进展。
Front Public Health. 2023 Nov 30;11:1282413. doi: 10.3389/fpubh.2023.1282413. eCollection 2023.
3
[Risk factors and resistance patterns of invasive infection in Children].[儿童侵袭性感染的危险因素及耐药模式]
Zhonghua Er Ke Za Zhi. 2022 Aug 2;60(8):762-768. doi: 10.3760/cma.j.cn112140-20220502-00404.
4
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.一项多中心研究:住院患者感染耐碳青霉烯类鲍曼不动杆菌的危险因素和结局。
Int J Infect Dis. 2010 Sep;14(9):e764-9. doi: 10.1016/j.ijid.2010.02.2254. Epub 2010 Jun 19.
5
Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.碳青霉烯类耐药鲍曼不动杆菌血流感染的临床转归:2 种单克隆株暴发的研究
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1057-62. doi: 10.1086/656247.
6
Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.多重耐药和广泛耐药鲍曼不动杆菌医院感染与高死亡率相关:儿科重症监护病房的回顾性研究。
BMC Infect Dis. 2020 Aug 12;20(1):597. doi: 10.1186/s12879-020-05321-y.
7
Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.埃塞俄比亚东北部德西综合专科医院住院患者中不动杆菌和铜绿假单胞菌医院感染的耐药谱及相关因素。一项横断面研究。
PLoS One. 2021 Nov 15;16(11):e0257272. doi: 10.1371/journal.pone.0257272. eCollection 2021.
8
Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.碳青霉烯类药物使用对重症监护病房患者不动杆菌感染患病率的影响。
Ann Clin Microbiol Antimicrob. 2014 Jan 9;13:7. doi: 10.1186/1476-0711-13-7.
9
Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.碳青霉烯类耐药和接受积极抗菌治疗对鲍曼不动杆菌血流感染临床结局的影响。
Antimicrob Agents Chemother. 2011 Oct;55(10):4844-9. doi: 10.1128/AAC.01728-10. Epub 2011 Aug 8.
10
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.希腊重症监护病房耐碳青霉烯类 versus 碳青霉烯类敏感鲍曼不动杆菌菌血症:危险因素、临床特征和结局。
Infection. 2010 Jun;38(3):173-80. doi: 10.1007/s15010-010-0008-1. Epub 2010 Mar 12.

本文引用的文献

1
Disinfectants and antiseptics: mechanisms of action and resistance.消毒剂和防腐剂:作用机制与耐药性
Nat Rev Microbiol. 2024 Jan;22(1):4-17. doi: 10.1038/s41579-023-00958-3. Epub 2023 Aug 30.
2
Global prevalence of nosocomial infection: A systematic review and meta-analysis.全球医院感染的患病率:系统评价和荟萃分析。
PLoS One. 2023 Jan 27;18(1):e0274248. doi: 10.1371/journal.pone.0274248. eCollection 2023.
3
Prevalence of nosocomial infections in Covid-19 patients admitted to the intensive care unit of Imam Khomeini complex hospital in Tehran.
德黑兰伊玛目霍梅尼综合医院重症监护病房收治的新冠肺炎患者医院感染的患病率
Iran J Microbiol. 2021 Dec;13(6):764-768. doi: 10.18502/ijm.v13i6.8075.
4
Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with Infection.治疗、临床结局和住院患者 感染死亡率的预测因素:一项全国性队列研究。
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0197521. doi: 10.1128/AAC.01975-21. Epub 2022 Jan 10.
5
Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome.抗菌药物耐药性:流行情况、经济负担、耐药机制和克服策略。
Eur J Pharm Sci. 2022 Mar 1;170:106103. doi: 10.1016/j.ejps.2021.106103. Epub 2021 Dec 20.
6
Association of capsular polysaccharide locus 2 with prognosis of bacteraemia.荚膜多糖基因座 2 与菌血症预后的关系。
Emerg Microbes Infect. 2022 Dec;11(1):83-90. doi: 10.1080/22221751.2021.2011624.
7
Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals.多重耐药鲍曼不动杆菌在医院的新关注点。
Mol Biol Rep. 2021 Oct;48(10):6987-6998. doi: 10.1007/s11033-021-06690-6. Epub 2021 Aug 30.
8
Nosocomial Infections: Do Not Forget the Parasites!医院感染:不要忘记寄生虫!
Pathogens. 2021 Feb 19;10(2):238. doi: 10.3390/pathogens10020238.
9
Infective endocarditis by species: a systematic review.种所致感染性心内膜炎:系统评价。
J Chemother. 2021 Jul;33(4):203-215. doi: 10.1080/1120009X.2020.1812804. Epub 2020 Sep 2.
10
Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii.多药耐药鲍曼不动杆菌的遗传学、流行病学和临床表现。
J Hosp Infect. 2020 Jan;104(1):4-11. doi: 10.1016/j.jhin.2019.09.021. Epub 2019 Oct 4.